Zions Bancorporation’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.28K | Buy |
28
+2
| +8% | +$337 | ﹤0.01% | 718 |
|
|
2024
Q3 | $5.04K | Sell |
26
-75
| -74% | -$15.7K | ﹤0.01% | 712 |
|
|
2024
Q2 | $23.4K | Sell |
101
-43
| -30% | -$9.35K | ﹤0.01% | 521 |
|
|
2024
Q1 | $31.1K | Sell |
144
-19
| -12% | -$4.45K | ﹤0.01% | 488 |
|
|
2023
Q4 | $42.2K | Buy |
163
+7
| +4% | +$1.72K | ﹤0.01% | 436 |
|
|
2023
Q3 | $40.1K | Sell |
156
-2
| -1% | -$535 | ﹤0.01% | 415 |
|
|
2023
Q2 | $45K | Hold |
158
| – | – | ﹤0.01% | 409 |
|
|
2023
Q1 | $43.9K | Sell |
158
-5
| -3% | -$1.38K | ﹤0.01% | 435 |
|
|
2022
Q4 | $45.1K | Sell |
163
-12
| -7% | -$3.39K | ﹤0.01% | 457 |
|
|
2022
Q3 | $47K | Sell |
175
-1
| -0.6% | -$212 | ﹤0.01% | 428 |
|
|
2022
Q2 | $36K | Sell |
176
-50
| -22% | -$10.2K | ﹤0.01% | 508 |
|
|
2022
Q1 | $48K | Buy |
226
+27
| +14% | +$5.87K | ﹤0.01% | 512 |
|
|
2021
Q4 | $48K | Sell |
199
-29
| -13% | -$7.46K | ﹤0.01% | 458 |
|
|
2021
Q3 | $65K | Sell |
228
-82
| -26% | -$26.9K | 0.01% | 420 |
|
|
2021
Q2 | $107K | Buy |
310
+121
| +64% | +$36.7K | 0.01% | 341 |
|
|
2021
Q1 | $53K | Sell |
189
-27
| -13% | -$7.28K | 0.01% | 417 |
|
|
2020
Q4 | $53K | Buy |
216
+2
| +0.9% | +$516 | 0.01% | 388 |
|
|
2020
Q3 | $61K | Sell |
214
-6
| -3% | -$1.67K | 0.01% | 341 |
|
|
2020
Q2 | $59K | Buy |
220
+1
| +0.5% | +$301 | 0.01% | 320 |
|
|
2020
Q1 | $69K | Sell |
219
-20
| -8% | -$6.07K | 0.01% | 288 |
|
|
2019
Q4 | $71K | Sell |
239
-29
| -11% | -$8.05K | 0.01% | 357 |
|
|
2019
Q3 | $62K | Sell |
268
-3
| -1% | -$699 | 0.01% | 384 |
|
|
2019
Q2 | $63K | Sell |
271
-696
| -72% | -$161K | 0.01% | 352 |
|
|
2019
Q1 | $229K | Buy |
967
+1
| +0.1% | +$315 | 0.04% | 190 |
|
|
2018
Q4 | $291K | Buy |
966
+537
| +125% | +$171K | 0.21% | 56 |
|
|
2018
Q3 | $152K | Buy |
429
+20
| +5% | +$6.89K | 0.04% | 202 |
|
|
2018
Q2 | $119K | Buy |
409
+80
| +24% | +$22.5K | 0.08% | 119 |
|
|
2018
Q1 | $90K | Sell |
329
-1,139
| -78% | -$354K | 0.02% | 202 |
|
|
2017
Q4 | $468K | Buy |
1,468
+204
| +16% | +$65.4K | 0.08% | 99 |
|
|
2017
Q3 | $396K | Buy |
1,264
+1,218
| +2,648% | +$361K | 0.06% | 176 |
|
|
2017
Q2 | $12K | Buy |
46
+10
| +28% | +$2.64K | ﹤0.01% | 323 |
|
|
2017
Q1 | $10K | Sell |
36
-185
| -84% | -$52.3K | ﹤0.01% | 363 |
|
|
2016
Q4 | $63K | Sell |
221
-3
| -1% | -$889 | 0.01% | 209 |
|
|
2016
Q3 | $67K | Buy |
224
+76
| +51% | +$22.5K | 0.01% | 201 |
|
|
2016
Q2 | $37K | Sell |
148
-79
| -35% | -$20.8K | 0.01% | 246 |
|
|
2016
Q1 | $64K | Sell |
227
-35
| -13% | -$9.24K | 0.01% | 207 |
|
|
2015
Q4 | $69K | Buy |
262
+25
| +11% | +$7.18K | 0.01% | 179 |
|
|
2015
Q3 | $70K | Buy |
+237
| New | +$78.3K | 0.01% | 173 |
|
|
2015
Q2 | – | Sell |
-255
| Closed | -$108K | – | 315 |
|
|
2015
Q1 | $108K | Buy |
+255
| New | +$101K | 0.02% | 161 |
|
Other funds holding BIIB
Zions Bancorporation's BIIB Position: Q4 2024 in Review
Zions Bancorporation increased its Biogen (BIIB) stake by 7.7% in Q4 2024, buying an estimated $337 and bringing the position to 28 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #718.
Zions Bancorporation first reported a position in BIIB in Q1 2015 and has held it in 39 quarters since. The position peaked at $468K in Q4 2017. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Zions Bancorporation held 28 shares of Biogen worth $4.28K as of Q4 2024.
- Zions Bancorporation bought 2 Biogen shares in Q4 2024, an estimated $337.
- Biogen made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #718 holding.
- Zions Bancorporation first reported a position in Biogen in Q1 2015 and has held it in 39 quarters since.
- Zions Bancorporation's Biogen position peaked at $468K in Q4 2017.
- 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.